Keyphrases
Metformin
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Patients with Heart Failure
100%
Sulfonylurea
80%
Chronic Heart Failure
60%
Scotland
40%
Confidence Interval
40%
Tayside
40%
Monotherapy
40%
Patients with Diabetes Mellitus
40%
Diabetes
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Observational Data
20%
Insulin
20%
Therapeutic Potential
20%
Health Informatics
20%
All-cause Mortality
20%
Oral Hypoglycemic Agents
20%
Patients with Chronic Heart Failure
20%
Metformin Therapy
20%
Metformin Monotherapy
20%
Comorbidity
20%
Cox Regression
20%
Large Cohort Study
20%
Prospective Clinical Trial
20%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Metformin
100%
Congestive Heart Failure
100%
Sulfonylurea
57%
Diabetes Mellitus
42%
Monotherapy
42%
Confidence Interval
28%
Patient with Diabetes
28%
Clinical Audit
14%
Information System
14%
Public Health Informatics
14%
Mortality Rate
14%
Cohort Analysis
14%
Carvedilol
14%
Oral Antidiabetic Agent
14%
All Cause Mortality
14%
Carbetimer
14%
Study Subject
14%
Proportional Hazards Model
14%
Comorbidity
14%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Glycon
100%
Congestive Heart Failure
100%
Sulfonylurea
57%
Diabetes Mellitus
42%
Monotherapy
42%
Patient with Diabetes
28%
Clinical Trial
14%
Mortality Rate
14%
Diabetes
14%
Health Informatics
14%
Cohort Analysis
14%
Study Subject
14%
Proportional Hazards Model
14%
All Cause Mortality
14%
Oral Antidiabetic Agent
14%
Carvedilol
14%
Carbetimer
14%
Comorbidity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Congestive Heart Failure
100%
Non Insulin Dependent Diabetes Mellitus
100%
Sulfonylurea
57%
Diabetes Mellitus
42%
Monotherapy
42%
Clinical Trial
14%
Cohort Study
14%
All Cause Mortality
14%
Mortality Rate
14%
Carvedilol
14%
Oral Antidiabetic Agent
14%
Carbetimer
14%
Comorbidity
14%